Endo Diversification Leads to Indevus Buyout
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 1 (Table of Contents)
Published: 5 Jan-2009
DOI: 10.3833/pdr.v2009.i1.95 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Endo Pharmaceuticals, the marketer of pain medications, has reached an agreement to acquire Indevus Pharmaceuticals in a deal that is intended to bolster its pipeline and expand its business beyond pain therapy...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS